Annual General Meeting Archive

2013

The Annual General Meeting was held on Tuesday, 5 March 2013.

Document
Minutes
Voting Results
Speech: Franz B. Humer, Chairman
Speech: Severin Schwan, CEO
Dividend for 2012
Media Release
Invitation

2012

The Annual General Meeting was held on Tuesday, 6 March 2012.

Document
Minutes
Voting results
Speech: Franz B. Humer, Chairman
Speech: Severin Schwan, CEO
Dividend for 2011
Media Release
Invitation

2011

The Annual General Meeting was held on Tuesday, 1 March 2011.

Document
Minutes
Voting results
Speech: Franz B. Humer, Chairman
Speech: Severin Schwan, CEO
New elected Members of the Board of Directors at the Annual General Meeting 2011:
Paul Bulcke (1954)
Dr. Christoph Franz (1960)
Peter R. Voser (1958)
Dividend for 2010
Media Release
Invitation

2010

The Annual General Meeting was held on Tuesday, 2 March 2010.

Document
Minutes
Speech: Franz B. Humer, Chairman
Speech: Severin Schwan, CEO
New elected Members of the Board of Directors at the Annual General Meeting 2010:
William M. Burns (1947)
Dr. Arthur D. Levinson (1950)
Dividend for 2009
Invitation

2009

The Annual General Meeting was held on Tuesday, 10 March 2009.

Document
Minutes
Speech: Franz B. Humer, Chairman
Speech: Severin Schwan, CEO
Dividend for 2008
Media Release
Invitation

2008

The Annual General Meeting was held on Tuesday, 4 March 2008.

Document
Minutes
Speech: Franz B. Humer, Chairman and CEO - Roche in 2007
Dividend for 2007
Media Release
Invitation

2007

The Annual General Meeting was held on Monday, 5 March 2007.

Document
Minutes
Speech: Franz B. Humer, Chairman and CEO - Roche in 2006
Speech: Arthur D. Levinson, Chairman and CEO Genentech Inc. - Genentech
New elected Members of the Board of Directors at the Annual General Meeting 2007:
Prof. Dr. Pius Baschera
Dr. Wolfgang Ruttenstorfer
Dividend for 2006
Media Release
Invitation

2006

The Annual General Meeting of the Roche Holding Ltd was held on 27 February 2006.

Document
Minutes
Speech: Franz B. Humer, Chairman and CEO - Roche in 2005
Speech:Jan van Koeveringe, Head Pharma Global Technical Operations - Avian influenza and Tamiflu
Dividend for 2005
Media Release
Invitation

Möchten Sie den Inhalt auf Deutsch lesen?

Zur deutschen Version
Zur deutschen Version

Discover more